The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
Author:
Funder
NIH grants
DOD grant
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference65 articles.
1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010
2. Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor;Godfrey;J Exp Med,1994
3. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses;Gramaglia;J Immunol,1998
4. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand;Murata;J Exp Med,2000
5. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1;Flynn;J Exp Med,1998
Cited by 131 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds;Journal of Controlled Release;2024-09
2. Analysis of the expression of cytokines and chemokines, platelet‐leukocyte aggregates, sCD40L and sCD62P in cutaneous melanoma;Journal of Surgical Oncology;2024-08-11
3. Efficacy of IFN-γ, sCD40L, and Poly(I:C) Treated Bone Marrow-Derived Macrophages in Murine Mammary Carcinoma;Immunological Investigations;2024-05-30
4. A trispecific antibody induces potent tumor-directed T-cell activation and antitumor activity by CD3/CD28 co-engagement;Immunotherapy;2024-02
5. Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin’s lymphoma;Cell Reports Medicine;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3